InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,923.60
(
0.39%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,685.08
(
1.50%
)
Post# of 252524
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: biomaven0 post# 201364

Thursday, 05/12/2016 1:40:36 PM

Thursday, May 12, 2016 1:40:36 PM

Post# of 252524
FGEN-3109

Do you know if they are actively working on follow on compound(s)? I ask for a couple reasons the IP can't be very good and Neff notably pointed out interest in Orphan indications. I am not a science guy so may be a dumb question but is it possible to PEGalyte or otherwise encapsulate an MAB to improve the bioavailability?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up